pH-sensitive nanoparticles decorated with three functional peptides delivered irinotecan plus miR-200 gene therapy to head and neck cancer, outperforming commercial Onivyde in mice.
Outperformed OnivydeTriple-peptide nanoparticle co-delivery of irinotecan + miR-200 exceeded commercial Onivyde efficacy and safety
What the researchers found
Triple-peptide pH-responsive nanoparticles co-delivering irinotecan and miR-200 outperformed Onivyde in a head and neck cancer mouse model by simultaneously targeting EMT, MDR, and Wnt pathways.
Why it matters
Head and neck cancers resist treatment through EMT and drug resistance pathways. Combining chemo with gene therapy in a single smart nanoparticle attacks both problems simultaneously.
The numbers in context
Outperformed Onivyde; regulated Wnt/beta-catenin, MDR, EMT pathways; 3 peptide types used for targeting
How the study worked
Nanoparticle design with pH-cleavable PEG + 3 peptides; physicochemical characterization; SAS cell cytotoxicity and uptake; pathway analysis (Wnt, MDR, EMT); in vivo SAS tumor-bearing mouse efficacy and safety studies; compared to Onivyde.
Who was studied
SAS tongue squamous carcinoma cells and SAS tumor-bearing mouse model
What this study cannot tell us
Mouse tumor model with single cancer type (tongue SCC); complex multi-component formulation may be hard to manufacture at scale; long-term toxicity not assessed.
How to read the evidence
Moderate — comprehensive preclinical study with in vivo efficacy comparison to an approved drug, but single cancer model.
When this study was published
Published in 2020; combination chemo/gene therapy nanoparticles remain an active development area.
The bigger picture
Peptide-decorated nanoparticles that respond to tumor acidity represent the frontier of precision cancer therapy — delivering multiple treatments exactly where needed while sparing healthy tissue.
Questions still open
- Can this multi-peptide nanoparticle platform be adapted for other cancer types?
- What are the manufacturing challenges for a 3-peptide + PEG + 2-drug nanoparticle?
- Would this approach work in combination with immunotherapy?
Common questions
How do the nanoparticles know to release drugs at the tumor?
Why combine chemo with gene therapy?
Read the original research
PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.
Theranostics, 10(15), 6695-6714
Citation
Lo, Yu-Li; Chang, Chih-Hsien; Wang, Chen-Shen; Yang, Muh-Hwa; Lin, Anya Maan-Yuh; Hong, Ci-Jheng; Tseng, Wei-Hsuan. (2020). PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.. Theranostics, 10(15), 6695-6714. https://doi.org/10.7150/thno.45164